118 related articles for article (PubMed ID: 20004201)
21. T cell-associated CD18 but not CD62L, ICAM-1, or PSGL-1 is required for the induction of chronic colitis.
Ostanin DV; Furr KL; Pavlick KP; Gray L; Kevil CG; Shukla D; D'Souza D; Hoffman JM; Grisham MB
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1706-14. PubMed ID: 17332469
[TBL] [Abstract][Full Text] [Related]
22. Allergic airway hyperresponsiveness, inflammation, and remodeling do not develop in phosphoinositide 3-kinase gamma-deficient mice.
Takeda M; Ito W; Tanabe M; Ueki S; Kato H; Kihara J; Tanigai T; Chiba T; Yamaguchi K; Kayaba H; Imai Y; Okuyama K; Ohno I; Sasaki T; Chihara J
J Allergy Clin Immunol; 2009 Apr; 123(4):805-12. PubMed ID: 19232703
[TBL] [Abstract][Full Text] [Related]
23. Protein kinase C theta plays a fundamental role in different types of chronic colitis.
Nagahama K; Ogawa A; Shirane K; Shimomura Y; Sugimoto K; Mizoguchi A
Gastroenterology; 2008 Feb; 134(2):459-69. PubMed ID: 18155708
[TBL] [Abstract][Full Text] [Related]
24. Protease-activated receptor-2 activation: a major actor in intestinal inflammation.
Hyun E; Andrade-Gordon P; Steinhoff M; Vergnolle N
Gut; 2008 Sep; 57(9):1222-9. PubMed ID: 18460552
[TBL] [Abstract][Full Text] [Related]
25. Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis.
Simpson SJ; Mizoguchi E; Allen D; Bhan AK; Terhorst C
Eur J Immunol; 1995 Sep; 25(9):2618-25. PubMed ID: 7589135
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
[TBL] [Abstract][Full Text] [Related]
27. Increased proliferation of middle to distal colonic cells during colorectal carcinogenesis in experimental murine ulcerative colitis.
Inoue T; Murano M; Kuramoto T; Ishida K; Kawakami K; Abe Y; Morita E; Murano N; Toshina K; Nishikawa T; Maemura K; Shimamoto C; Hirata I; Katsu K; Higuchi K
Oncol Rep; 2007 Dec; 18(6):1457-62. PubMed ID: 17982630
[TBL] [Abstract][Full Text] [Related]
28. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
Itzkowitz SH; Yio X
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G7-17. PubMed ID: 15194558
[TBL] [Abstract][Full Text] [Related]
29. Ameliorating effect of saporin-conjugated anti-CD11b monoclonal antibody in a murine T-cell-mediated chronic colitis.
Kanai T; Uraushihara K; Totsuka T; Nemoto Y; Fujii R; Kawamura T; Makita S; Sawada D; Yagita H; Okumura K; Watanabe M
J Gastroenterol Hepatol; 2006 Jul; 21(7):1136-42. PubMed ID: 16824065
[TBL] [Abstract][Full Text] [Related]
30. Pivotal roles of interleukin-6 in transmural inflammation in murine T cell transfer colitis.
Kitamura K; Nakamoto Y; Kaneko S; Mukaida N
J Leukoc Biol; 2004 Dec; 76(6):1111-7. PubMed ID: 15339938
[TBL] [Abstract][Full Text] [Related]
31. Polyclonal expansion of adoptively transferred CD4+ alpha beta T cells in the colonic lamina propria of scid mice with colitis.
Rudolphi A; Bonhagen K; Reimann J
Eur J Immunol; 1996 May; 26(5):1156-63. PubMed ID: 8647181
[TBL] [Abstract][Full Text] [Related]
32. Ibadronate may prevent colorectal carcinogenesis in mice with ulcerative colitis.
Sassa S; Okabe H; Nemoto N; Kikuchi H; Kudo H; Sakamoto S
Anticancer Res; 2009 Nov; 29(11):4615-9. PubMed ID: 20032411
[TBL] [Abstract][Full Text] [Related]
33. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
[TBL] [Abstract][Full Text] [Related]
34. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.
Tamaki H; Nakamura H; Nishio A; Nakase H; Ueno S; Uza N; Kido M; Inoue S; Mikami S; Asada M; Kiriya K; Kitamura H; Ohashi S; Fukui T; Kawasaki K; Matsuura M; Ishii Y; Okazaki K; Yodoi J; Chiba T
Gastroenterology; 2006 Oct; 131(4):1110-21. PubMed ID: 17030181
[TBL] [Abstract][Full Text] [Related]
35. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
Liu Z; Jiu J; Liu S; Fa X; Li F; Du Y
J Autoimmun; 2007; 29(2-3):187-94. PubMed ID: 17804196
[TBL] [Abstract][Full Text] [Related]
36. Dextran sodium sulfate-induced murine inflammatory colitis model.
Schneider M
Methods Mol Biol; 2013; 1031():189-95. PubMed ID: 23824901
[TBL] [Abstract][Full Text] [Related]
37. VEGFR2 Signaling Prevents Colorectal Cancer Cell Senescence to Promote Tumorigenesis in Mice With Colitis.
Foersch S; Sperka T; Lindner C; Taut A; Rudolph KL; Breier G; Boxberger F; Rau TT; Hartmann A; Stürzl M; Wittkopf N; Haep L; Wirtz S; Neurath MF; Waldner MJ
Gastroenterology; 2015 Jul; 149(1):177-189.e10. PubMed ID: 25797700
[TBL] [Abstract][Full Text] [Related]
38. Inflammation and colorectal cancer.
Kraus S; Arber N
Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
[TBL] [Abstract][Full Text] [Related]
39. Novel application of proton pump inhibitor for the prevention of colitis-induced colorectal carcinogenesis beyond acid suppression.
Kim YJ; Lee JS; Hong KS; Chung JW; Kim JH; Hahm KB
Cancer Prev Res (Phila); 2010 Aug; 3(8):963-74. PubMed ID: 20628001
[TBL] [Abstract][Full Text] [Related]
40. Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis.
Yeo M; Kim DK; Park HJ; Oh TY; Kim JH; Cho SW; Paik YK; Hahm KB
Proteomics; 2006 Feb; 6(4):1158-65. PubMed ID: 16402363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
